Brief: Terns Pharmaceuticals Cash & Cash Equivalents Expected To Provide Runway Into 2028
25/02/2025 14:37
Feb 25 (Reuters) - Terns Pharmaceuticals Inc TERN.O: TERNS PHARMACEUTICALS: CASH & CASH EQUIVALENTS EXPECTED TO PROVIDE RUNWAY INTO 2028 TERNS PHARMACEUTICALS: ON TRACK TO INITIATE TERN-601 PHASE 2 FALCON STUDY IN EARLY 2Q25 WITH 12-WEEK DATA EXPECTED 2H25 Source text: ID:nGNX3SVjhF Further company coverage: TERN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Terns Pharmaceuticals
See all newsNASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. RESEARCH ROUNDUP-East West Bancorp, Reliance, S&P Global
Brief: Merck Announces Expiration Of Hart-Scott-Rodino Act Waiting Period To Acquire Terns Pharmaceuticals
Brief: Merck Begins Tender Offer To Acquire Terns Pharmaceuticals, Inc.